Chronic Kidney Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults (men and women)
• People who have been diagnosed with Chronic Kidney Disease at a moderate stage, specifically with a kidney filtration rate between 30 and 90 mL/min/1.73m² (known as KDIGO stage G2 or G3)
• People who have a moderate-to-high level of protein (albumin) in their urine, within a specific range of 3 to 200 mg/mmol, but not at the highest ("nephrotic") levels
• People with a body weight in the range considered moderate, specifically a Body Mass Index (BMI) between 18 and 40
• People whose current daily eating window spans about 12 hours (meaning all meals and snacks are consumed within a 12-hour period each day, as reported by the person and confirmed during a preparation phase)
• People who are able to understand and agree to the study procedures and commit to the full duration of the trial
• People who are comfortable using a smartphone (compatible with iOS or Android) and able to regularly photograph their food and drinks using a specific app called MyFoodRepo

Who may not be able to join:

• Women who are pregnant, breastfeeding, or planning to become pregnant during the study
• People who have a diagnosed eating disorder
• People who are currently following a low-carbohydrate, ketogenic, or calorie-restricted diet (note: exclusions for food intolerances, or vegan or vegetarian diets, do not apply here)
• People with high blood pressure that is not well controlled (above 160/100 mmHg)
• People who have diabetes and are taking medications that can cause low blood sugar (hypoglycemia) — however, people with prediabetes, or diabetes managed without such medications or with no medication at all, may still be considered
• People currently taking oral corticosteroid medications (steroid tablets)
• People with poorly controlled diabetes, indicated by a blood sugar marker (HbA1c) above 8.5%
• People with an active cancer diagnosis or who have received cancer treatment within the past 12 months
• People with a major mental illness
• Women who drink more than 7 standard alcoholic drinks per week, or men who drink more than 14 standard alcoholic drinks per week
• People who work evening or night shifts, or who plan to do so during the study
• People who plan to travel to a time zone that differs by 2 or more hours during the study
• People whose kidney-related or other relevant medications have been changed in the last 3 months (including, but not limited to, ACE inhibitors, SGLT2 inhibitors, or finerenone)
• People who have recently been diagnosed with a kidney inflammation condition (glomerulonephritis) and are taking more than 2 immune-suppressing medications
• People who have received a kidney transplant within the past year
• People who are currently enrolled in, or have been enrolled in, another clinical trial involving a medication or medical device within the past month, or who plan to join one during the study

Important: Always verify eligibility with the trial site directly before applying.